The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 29, 2023

Filed:

Oct. 05, 2020
Applicant:

Javelin Biotech, Inc., Woburn, MA (US);

Inventors:

Murat Cirit, Cambridge, MA (US);

Begum Alaybeyoglu, Cambridge, MA (US);

Jason Samuel Sherfey, Somerville, MA (US);

John Wayne Rumsey, Somerville, MA (US);

Yoojin Shin, Burlington, MA (US);

Assignee:

Javelin Biotech, Inc., Woburn, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/10 (2006.01); B01L 3/00 (2006.01); G01N 21/3504 (2014.01); G01N 33/00 (2006.01); G01N 33/574 (2006.01); G01N 21/64 (2006.01); A61K 45/06 (2006.01); G01N 21/35 (2014.01); G01N 33/50 (2006.01); G01N 33/543 (2006.01); B01L 3/02 (2006.01); G01N 33/53 (2006.01); C12M 3/06 (2006.01);
U.S. Cl.
CPC ...
B01L 3/502715 (2013.01); C12M 23/16 (2013.01); G01N 33/5058 (2013.01); B01L 2300/0816 (2013.01); B01L 2300/0858 (2013.01); B01L 2300/0861 (2013.01); B01L 2300/123 (2013.01); G01N 2570/00 (2013.01);
Abstract

A microphysiological system (MPS) includes at least one first inlet for receiving a fluid medium. The MPS includes a brain module comprising brain tissue. The MPS includes a blood-brain-barrier (BBB) module comprising BBB tissue, the BBB module configured to receive the fluid medium. The MPS includes a crosstalk channel between the brain module and the BBB module, the crosstalk channel configured to promote a bidirectional crosstalk between the brain tissue and the BBB tissue in response to receiving the fluid medium at the BBB module. The MPS is configured for treating the brain tissue and the BBB tissue with a drug or a combination of drugs to determine a phenotypic effect and a transcriptomic effect of the drug. A drug perturbation is related to the phenotypic effect and the transcriptomic effect based on kinetic optimization.


Find Patent Forward Citations

Loading…